Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT02971397 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

PROCEDURE: Bone Marrow Aspiration and Biopsy
DRUG: Cytarabine
DRUG: Daunorubicin Hydrochloride
OTHER: Laboratory Biomarker Analysis

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]